Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bladder cancer surgery: new clues in fluid and DNA may predict recurrence

NCT ID NCT07589413

Recruiting now Knowledge-focused Sponsor: Zhiping Wang Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for 150 adults having surgery for bladder cancer. Researchers want to see if the amount of fluid absorbed during surgery and changes in DNA in the blood can help predict if the cancer will return or get worse. The goal is to improve how doctors assess risk and plan follow-up care after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bladder transitional cell carcinoma Disease Progression neoplasm Recurrence transitional cell carcinoma urinary bladder cancer urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER BLADDER CANCER RECURRENCE PROGRESSION OF BLADDER CANCER TRANSURETHRAL RESECTION OF BLADDER TUMOR UROTHELIAL CARCINOMA OF THE BLADDER

Contacts and locations

Locations

  • The Second Hospital of Lanzhou University

    RECRUITING

    Lanzhou, Gansu, 730030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.